Home › Irritable Bowel Syndrome › Illinois
Irritable Bowel Syndrome clinical trials in Illinois
4 studies for Irritable Bowel Syndrome are looking for participants at sites in Illinois.
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)
- Springfield Clinic - First, Springfield
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 22, 2026 · NCT07545759A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
- GSK Investigational Site, Morton
- GSK Investigational Site, Oak Lawn
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 22, 2026 · NCT07519395A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)
- Springfield Clinic - First, Springfield
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 22, 2026 · NCT07545772A Prospective Trial of a Variable Compression System for Moderate to Severe Irritable Bowel Syndrome
- UChicago Medicine AdventHealth Medical Group Gastroenterology at Bolingbrook, Bolingbrook
Recruiting
Ages 18 to 60 · All sexes · Updated Apr 29, 2026 · NCT07540312From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.